GSA Capital Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.33M | Buy |
+19,820
| New | +$1.32M | 0.08% | 339 |
|
|
2026
Q1 | – | Sell |
-10,778
| Closed | -$715K | – | 1826 |
|
|
2025
Q4 | $715K | Buy |
+10,778
| New | +$697K | 0.06% | 575 |
|
|
2025
Q1 | – | Sell |
-3,981
| Closed | -$310K | – | 1757 |
|
|
2024
Q4 | $310K | Sell |
3,981
-6,287
| -61% | -$465K | 0.02% | 1182 |
|
|
2024
Q3 | $688K | Buy |
10,268
+5,787
| +129% | +$475K | 0.05% | 703 |
|
|
2024
Q2 | $508K | Sell |
4,481
-1,650
| -27% | -$209K | 0.04% | 953 |
|
|
2024
Q1 | $850K | Sell |
6,131
-3,332
| -35% | -$419K | 0.07% | 548 |
|
|
2023
Q4 | $1.17M | Buy |
9,463
+3,575
| +61% | +$365K | 0.1% | 311 |
|
|
2023
Q3 | $549K | Buy |
+5,888
| New | +$664K | 0.05% | 732 |
|
|
2023
Q2 | – | Sell |
-8,100
| Closed | -$941K | – | 1603 |
|
|
2023
Q1 | $941K | Buy |
8,100
+4,946
| +157% | +$554K | 0.09% | 349 |
|
|
2022
Q4 | $357K | Sell |
3,154
-1,042
| -25% | -$114K | 0.04% | 813 |
|
|
2022
Q3 | $338K | Sell |
4,196
-4,763
| -53% | -$403K | 0.04% | 850 |
|
|
2022
Q2 | $668K | Buy |
+8,959
| New | +$818K | 0.1% | 326 |
|
|
2022
Q1 | – | Sell |
-5,508
| Closed | -$739K | – | 1507 |
|
|
2021
Q4 | $739K | Buy |
+5,508
| New | +$791K | 0.09% | 359 |
|
|
2021
Q3 | – | Sell |
-5,844
| Closed | -$624K | – | 1522 |
|
|
2021
Q2 | $624K | Buy |
5,844
+308
| +6% | +$29.6K | 0.07% | 491 |
|
|
2021
Q1 | $497K | Buy |
+5,536
| New | +$520K | 0.08% | 355 |
|
|
2019
Q2 | – | Sell |
-187,420
| Closed | -$5.58M | – | 1507 |
|
|
2019
Q1 | $5.58M | Buy |
+187,420
| New | +$6.59M | 0.57% | 4 |
|
|
2018
Q4 | – | Sell |
-16,992
| Closed | -$608K | – | 1428 |
|
|
2018
Q3 | $608K | Sell |
16,992
-11,556
| -40% | -$358K | 0.03% | 975 |
|
|
2018
Q2 | $678K | Buy |
+28,548
| New | +$605K | 0.03% | 988 |
|
|
2017
Q1 | – | Sell |
-44,456
| Closed | -$664K | – | 1792 |
|
|
2016
Q4 | $664K | Buy |
+44,456
| New | +$788K | 0.04% | 811 |
|
|
2016
Q2 | – | Sell |
-46,096
| Closed | -$783K | – | 1770 |
|
|
2016
Q1 | $783K | Sell |
46,096
-25,904
| -36% | -$433K | 0.05% | 699 |
|
|
2015
Q4 | $1.47M | Sell |
72,000
-33,564
| -32% | -$698K | 0.07% | 434 |
|
|
2015
Q3 | $2.27M | Buy |
105,564
+18,128
| +21% | +$404K | 0.11% | 212 |
|
|
2015
Q2 | $1.75M | Sell |
87,436
-60,400
| -41% | -$1.06M | 0.07% | 478 |
|
|
2015
Q1 | $2.3M | Buy |
147,836
+2,784
| +2% | +$42.1K | 0.09% | 264 |
|
|
2014
Q4 | $2M | Buy |
145,052
+56,520
| +64% | +$692K | 0.14% | 148 |
|
|
2014
Q3 | $885K | Buy |
88,532
+7,292
| +9% | +$74.5K | 0.05% | 571 |
|
|
2014
Q2 | $805K | Buy |
81,240
+36,444
| +81% | +$323K | 0.04% | 814 |
|
|
2014
Q1 | $463K | Sell |
44,796
-50,672
| -53% | -$524K | 0.03% | 833 |
|
|
2013
Q4 | $845K | Buy |
+95,468
| New | +$756K | 0.07% | 473 |
|
Other funds holding DXCM
GSA Capital Partners's DXCM Position: Q2 2026 in Review
GSA Capital Partners opened a new position in DexCom (DXCM) in Q2 2026: 19,820 shares worth $1.33M. The stake represents 0.08% of the portfolio and ranks #339 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in DXCM as recently as Q4 2025.
GSA Capital Partners first reported a position in DXCM in Q4 2013 and has held it in 29 quarters since. The position peaked at $5.58M in Q1 2019. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- GSA Capital Partners held 19,820 shares of DexCom worth $1.33M as of Q2 2026.
- DexCom was a new GSA Capital Partners position in Q2 2026.
- DexCom made up 0.08% of GSA Capital Partners's portfolio in Q2 2026, its #339 holding.
- GSA Capital Partners first reported a position in DexCom in Q4 2013 and has held it in 29 quarters since.
- GSA Capital Partners's DexCom position peaked at $5.58M in Q1 2019.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.